Immunocore Holdings plc
IMCR
$31.16
-$0.05-0.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 333.58M | 310.20M | 296.31M | 280.91M | 265.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 333.58M | 310.20M | 296.31M | 280.91M | 265.27M |
| Cost of Revenue | -42.22M | -42.81M | -1.64M | -11.23M | -25.50M |
| Gross Profit | 375.80M | 353.01M | 297.95M | 292.14M | 290.77M |
| SG&A Expenses | 156.69M | 155.78M | 154.91M | 154.84M | 151.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.05M | -18.05M | 897.00K | 897.00K | 897.00K |
| Total Operating Expenses | 363.12M | 362.61M | 365.27M | 355.51M | 337.61M |
| Operating Income | -29.54M | -52.41M | -68.96M | -74.60M | -72.34M |
| Income Before Tax | -22.77M | -52.94M | -53.76M | -59.12M | -65.81M |
| Income Tax Expenses | -1.15M | -1.85M | -6.71M | -4.24M | -5.54M |
| Earnings from Continuing Operations | -21.63 | -51.09 | -47.05 | -54.88 | -60.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.63M | -51.09M | -47.05M | -54.88M | -60.27M |
| EBIT | -29.54M | -52.41M | -68.96M | -74.60M | -72.34M |
| EBITDA | -25.49M | -48.21M | -64.89M | -70.49M | -68.19M |
| EPS Basic | -0.43 | -1.02 | -0.95 | -1.10 | -1.22 |
| Normalized Basic EPS | -0.30 | -0.61 | -0.68 | -0.74 | -0.83 |
| EPS Diluted | -0.44 | -1.03 | -0.95 | -1.10 | -1.22 |
| Normalized Diluted EPS | -0.31 | -0.62 | -0.68 | -0.74 | -0.83 |
| Average Basic Shares Outstanding | 200.17M | 199.96M | 199.45M | 198.56M | 197.24M |
| Average Diluted Shares Outstanding | 204.82M | 202.75M | 202.23M | 203.58M | 202.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |